share_log

Stephens & Co. Initiates Coverage On Medifast With Equal-Weight Rating, Announces Price Target of $82

Stephens & Co. Initiates Coverage On Medifast With Equal-Weight Rating, Announces Price Target of $82

Stephens & Co.以同等权重评级开始对Medifast进行报道,宣布目标价为82美元
Benzinga ·  2023/10/13 05:00

Stephens & Co. analyst Jim Salera initiates coverage on Medifast (NYSE:MED) with a Equal-Weight rating and announces Price Target of $82.

Stephens&Co.分析师吉姆·萨莱拉在Medifast(纽约证券交易所代码:MED)上以同等权重评级发起报道,并宣布目标价为82美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发